重组人CEACAM7(癌胚抗原相关细胞粘附分子7)

特别提示：包括重组人CEACAM7(癌胚抗原相关细胞粘附分子7)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人CEACAM7(癌胚抗原相关细胞粘附分子7)
英文名称：Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7

产品货号：重组人CEACAM7(癌胚抗原相关细胞粘附分子7)
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Thr36-Phe142在C端含有His标签。

CEACAM7质量控制：＞95%(还原性SDS-PAGE)

CEACAM7制剂：冻干品

CEACAM7保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

CEACAM7复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于CEACAM7：
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 (CEACAM7) is a member of the immunoglobulin superfamily A and CEA family. CEACAM7 localizes to the cell membrane and contains one Ig-like C2-type domain and one Ig-like V-type domain. The expression of CEACAM7 is significantly decreased in rectal cancer. Differences in CEACAM7 expression levels between long-term survivors and those with recurrent disease introduce a potential tumor marker to define a subset of patients who benefit most from adjuvant therapy.

除了重组人CEACAM7(癌胚抗原相关细胞粘附分子7),，我公司还供应以下相关产品：



名称：重组小鼠TNFSF11(RANK L)
货号：JN0484
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ala73-Asp316在C端含有His标签。

RANK L/TNFSF11质量控制：＞95%(还原性SDS-PAGE)

RANK L/TNFSF11制剂：冻干品

RANK L/TNFSF11保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

RANK L/TNFSF11复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于RANK L/TNFSF11：
Mouse tumor necrosis factor ligand superfamily member 11(Tnfsf11) is a member of the tumor necrosis factor (TNF) cytokine family. Tnfsf11 is widely expressed in cells including T cells and T cell rich organs, such as thymus and lymph nodes. This cytokine can bind to TNFRSF11B/OPG andTNFRSF11A/RANK. Tnfsf11 is involved in a number of fundamental biological processes such as acting as regulator of interactions between T-cells and dendritic cells, the regulation of the T-cell-dependent immune response and enhancing bone-resorption in humoral hypercalcemia of malignancy. It augments the ability of dendritic cells to stimulate naive T-cell proliferation.